Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Precision Equine, LLC
483
•Precision Equine, LLC•September 22, 2023

Precision Equine, LLC – FDA 483, Sep 22, 2023

Record Details

During an inspection conducted from August 23 to September 22, 2023, the U.S. Food and Drug Administration (FDA) issued a Form 483 to Precision Equine, LLC, a producer of sterile and non-sterile drug products located in Bakersfield, CA. This report details significant observations indicating a lack of adherence to manufacturing regulations, as outlined in the Federal Food, Drug, and Cosmetic Act.Key issues highlighted include inadequate procedures to prevent microbiological contamination in sterile drug products. Specifically, the company failed to perform frequent environmental and personnel monitoring, did not properly sanitize materials entering sterile environments, and exhibited poor aseptic technique. Facility design also had deficiencies, and hold times for depyrogenated supplies were not validated. The inspection further identified an absence of a comprehensive stability testing program, leading to extended product shelf-lives without sterility assurance. Potency testing was not routinely conducted for most finished drug batches before release, and both sterile and non-sterile finished products lacked essential microbiological testing. Equipment was found to be unclean with various stains and residues. The company failed to conduct identity testing for bulk drug substances or adequately validate supplier certificates of analysis for critical components. Additionally, investigations into unexplained discrepancies were not documented, and the quality control unit used ungraded ingredients. Precision Equine, LLC is required to address these serious observations with prompt corrective actions to ensure product quality and safety.

Company
Precision Equine, LLC
Inspection date
September 22, 2023
Product type
Drugs
Office
Los Angeles District Office
People
  • Sara H. Gabel
  • Julia N. Alvarez
  • Taichun Qin (Consumer Safety Officer, Drug Specialist)
View Company Profile

ID · 5bc8cc56-679a-4661-b259-b48b8ece4f09

Other documents for Precision Equine, LLC
  • UNTITLED_LETTER - 2023-09-22September 22, 2023
  • 483_RESPONSE - 2023-09-22September 22, 2023
  • UNTITLED_LETTER - 2023-09-12September 12, 2023

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Precision Equine, LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.